Cronos Group, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada?s Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group was incorporated in January, 2013 and is based in Toronto, Canada.
The current price of CRON is $2.54 USD — it has decreased by -1.17% in the past 24 hours. Watch Cronos Group stock price performance more closely on the chart.
What is Cronos Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cronos Group stocks are traded under the ticker CRON.
Is Cronos Group stock price growing?▼
CRON stock has fallen by -4.15% compared to the previous week, the month change is a -1.55% fall, over the last year Cronos Group has showed a +28.28% increase.
What is Cronos Group market cap?▼
Today Cronos Group has the market capitalization of 969.25M
What is Cronos Group revenue for the last year?▼
Cronos Group revenue for the last year amounts to 293.17M USD.
What is Cronos Group net income for the last year?▼
CRON net income for the last year is -18.89M USD.
How many employees does Cronos Group have?▼
As of May 11, 2026, the company has 459 employees.
In which sector is Cronos Group located?▼
Cronos Group operates in the Health & Wellness sector.
When did Cronos Group complete a stock split?▼
Cronos Group has not had any recent stock splits.
Where is Cronos Group headquartered?▼
Cronos Group is headquartered in Stayner, United States.